APA
Piccart M. J., Bertelsen K., Stuart G., Cassidy J., Mangioni C., Simonsen E., James K., Kaye S., Vergote I., Blom R., Grimshaw R., Atkinson R., Swenerton K., Trope C., Nardi M., Kaern J., Tumolo S., Timmers P., Roy J., Lhoas F., Lidvall B., Bacon M., Birt A., Andersen J., Zee B., Paul J., Pecorelli S., Baron B. & McGuire W. (20040408). Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
Chicago
Piccart M J, Bertelsen K, Stuart G, Cassidy J, Mangioni C, Simonsen E, James K, Kaye S, Vergote I, Blom R, Grimshaw R, Atkinson R, Swenerton K, Trope C, Nardi M, Kaern J, Tumolo S, Timmers P, Roy J-A, Lhoas F, Lidvall B, Bacon M, Birt A, Andersen J, Zee B, Paul J, Pecorelli S, Baron B and McGuire W. 20040408. Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
Harvard
Piccart M. J., Bertelsen K., Stuart G., Cassidy J., Mangioni C., Simonsen E., James K., Kaye S., Vergote I., Blom R., Grimshaw R., Atkinson R., Swenerton K., Trope C., Nardi M., Kaern J., Tumolo S., Timmers P., Roy J., Lhoas F., Lidvall B., Bacon M., Birt A., Andersen J., Zee B., Paul J., Pecorelli S., Baron B. and McGuire W. (20040408). Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
MLA
Piccart M J, Bertelsen K, Stuart G, Cassidy J, Mangioni C, Simonsen E, James K, Kaye S, Vergote I, Blom R, Grimshaw R, Atkinson R, Swenerton K, Trope C, Nardi M, Kaern J, Tumolo S, Timmers P, Roy J-A, Lhoas F, Lidvall B, Bacon M, Birt A, Andersen J, Zee B, Paul J, Pecorelli S, Baron B and McGuire W. Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer. : International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 20040408.